Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2791760
Reference Type
Journal Article
Title
Drug release from injectable depots: two different in vitro mechanisms
Author(s)
Wang, LW; Venkatraman, S; Kleiner, L
Year
2004
Is Peer Reviewed?
Yes
Journal
Journal of Controlled Release
ISSN:
0168-3659
EISSN:
1873-4995
Volume
99
Issue
2
Page Numbers
207-216
Language
English
PMID
15380631
DOI
10.1016/j.jconrel.2004.06.021
Web of Science Id
WOS:000224595400002
Abstract
Certain poly (lactide-co-glycolide) (PLGA)/benzyl benzoate (BB) solutions can form gels when injected into buffer (depot formation) as well as upon ageing under ambient conditions. When evaluating various PLGAs in benzyl benzoate, we have found that only those that gel upon ageing also form gel depots in buffer. This indicates that depot formation in this system may be fundamentally different from the phase inversion depot formation that has been observed for PLGA in water-miscible solvents. The drug release kinetics in vitro is controlled both by diffusion and erosion, with the base form of the drug being always released faster than its salt form. This is due to base-catalyzed hydrolysis. While gel permeation chromatography (GPC) measurements show a continuous decrease in molecular weight, the rheological properties upon buffer injection show maxima, for the base drug and the salt drug. The location of the viscosity maximum with time is dependent on the nature of the drug and its concentration.
Keywords
poly (lactide-co-glycolide) (PLGA); benzyl benzoate (BB); gelation; metoclopramide; in vitro
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity